65 research outputs found
Role of the Microbiota in Skin Neoplasms: New Therapeutic Horizons
The skin and the gut are regularly colonized by a variety of microorganisms capable of
interacting with the immune system through their metabolites and influencing the balance between
immune tolerance and inflammation. Alterations in the composition and diversity of the skin
microbiota have been described in various cutaneous diseases, including skin cancer, and the actual
function of the human microbiota in skin carcinogenesis, such as in progression and metastasis, is
currently an active area of research. The role of Human Papilloma Virus (HPV) in the pathogenesis of
squamous cell carcinoma is well consolidated, especially in chronically immunosuppressed patients.
Furthermore, an imbalance between Staphylococcus spp., such as Staphylococcus epidermidis and
aureus, has been found to be strongly related to the progression from actinic keratosis to squamous
cell carcinoma and differently associated with various stages of the diseases in cutaneous T-cell
lymphoma patients. Also, in melanoma patients, differences in microbiota have been related to
dissimilar disease course and prognosis and may affect the effectiveness and tolerability of immune
checkpoint inhibitors, which currently represent one of the best chances of a cure. From this point of
view, acting on microbiota can be considered a possible therapeutic option for patients with advanced
skin cancers, even if several issues are still open
An unusual cutaneous infection caused by Mycobacterium marinum
Introduction.
Mycobacterium marinum
is a non-tubercular mycobacterium residing in fresh or salt water (in tropical or temperate areas); it is a fish and human pathogen, and in immunocompromised patients can cause severe cutaneous and subcutaneous infections.Case presentation.A 46-year-old white man who underwent immunosuppressive therapy was admitted to our department in May 2016 for skin lesions previously diagnosed as 'unusual erysipelas'. We rejected the hypothesis of erysipelas, due to the clinical features, and our diagnostic hypotheses were oriented towards sporotrichosis, atypical mycobacteriosis, cutaneous tuberculosis and cutaneous sarcoidosis. Histological examination performed after a skin biopsy was compatible with a diagnosis of sporotrichosis. However, PCR performed on fresh tissue demonstrated the presence ofM. marinum.Conclusion.The case reported is interesting for the unusual clinical localization and modality of infection. The patient became infected by contact with contaminated remains or in the sea, in a geographical area not endemic forM.marinum. The previous state of immunosuppression favoured infection; however, the presence ofM. marinumin this area suggests a possible tropicalization of the water of the Mediterranean Sea. To our knowledge, this case is the only one reported in the literature with this modality of infection and in that geographical area
Inflammatory Cutaneous Diseases in Renal Transplant Recipients.
Kidney transplant recipients frequently suffer from skin infections and malignancies, possibly due to the effects of long-term immunosuppressive therapy. While the relationships between immunosuppression and these pathological conditions have been widely investigated, little is known about the relative incidence and characteristics of inflammatory skin diseases in this type of patient. In this study, we analyze the incidence of a number of inflammatory cutaneous diseases in a cohort of patients who underwent kidney transplantation. Although our study shows a relatively low incidence of these pathologies in transplanted patients-in agreement with the general action of immunosuppressant therapies in reducing inflammation-we scored a different efficacy of the various immunosuppressive regimens on inflammatory and autoimmune skin diseases. This information can be key for designing immunosuppressive regimens and devising accurate follow-up protocols
Non-Invasive Analysis of Actinic Keratosis before and after Topical Treatment Using a Cold Stimulation and Near-Infrared Spectroscopy
Background and objectives: The possible evolution of actinic keratoses (AKs) into invasive squamous cell carcinomas (SCC) makes their treatment and monitoring essential. AKs are typically monitored before and after treatment only through a visual analysis, lacking a quantitative measure to determine treatment effectiveness. Near-infrared spectroscopy (NIRS) is a non-invasive measure of the relative change of oxy-hemoglobin and deoxy-hemoglobin (O2Hb and HHb) in tissues. The aim of our study is to determine if a time and frequency analysis of the NIRS signals acquired from the skin lesion before and after a topical treatment can highlight quantitative differences between the AK skin lesion area. Materials and Methods: The NIRS signals were acquired from the skin lesions of twenty-two patients, with the same acquisition protocol: baseline signals, application of an ice pack near the lesion, removal of ice pack and acquisition of vascular recovery. We calculated 18 features from the NIRS signals, and we applied multivariate analysis of variance (MANOVA) to compare differences between the NIRS signals acquired before and after the therapy. Results: The MANOVA showed that the features computed on the NIRS signals before and after treatment could be considered as two statistically separate groups, after the ice pack removal. Conclusions: Overall, the NIRS technique with the cold stimulation may be useful to support non-invasive and quantitative lesion analysis and regression after a treatment. The results provide a baseline from which to further study skin lesions and the effects of various treatments
Efficacy of new class I medical device for actinic keratoses: a randomized controlled prospective study
AbstractBackground: The presence of Actinic Keratoses (AKs) represent the most important warning sign of subclinical ultraviolet radiation. Currently, the regular use of sunscreens is considered es..
AKASI and Near-Infrared Spectroscopy in the combined effectiveness evaluation of an actinic keratoses preventive product in immunocompetent and immunocompromised patients
Introduction: The high incidence of actinic keratoses among both the elderly population and immunocompromised subjects and the considerable risk of progression from in situ to invasive neoplasms makes it essential to identify new prevention, treatment, and monitoring strategies.Objective: The aim of this study was to evaluate the efficacy on AKs of a topical product ((R) Rilastil AK Repair 100 +) containing high-protection sunscreens, a DNA Repair Complex with antioxidant and repairing action against UV-induced DNA damage, and nicotinamide, a water-soluble derivative of vitamin B3 that demonstrated several photoprotective effects both in vitro and in vivo.Methods: The study enrolled 74 Caucasian patients, which included 42 immunocompetent and 32 immunosuppressed subjects. The efficacy of the treatment has been evaluated through the clinical index AKASI score and the non-invasive Near-Infrared Spectroscopy method.Results: The AKASI score proved to be a valid tool to verify the efficacy of the product under study, highlighting an average percentage reduction at the end of treatment of 31.37% in immunocompetent patients and 22.76% in organ transplant recipients, in comparison to the initial values, with a statistically significant reduction also in the single time intervals (T0 vs. T1 and T1 vs. T2) in both groups. On the contrary, the Near-Infrared Spectroscopy (a non-invasive technique that evaluates hemoglobin relative concentration variations) did not find significant differences for O(2)Hb and HHb signals before and after the treatment, probably because the active ingredients of the product under study can repair the photo-induced cell damage, but do not significantly modify the vascularization of the treated areas.Conclusion: The results deriving from this study demonstrate the efficacy of the product under study, confirming the usefulness of the AKASI score in monitoring treated patients. Near-Infrared Spectroscopy could represent an interesting strategy for AK patients monitoring, even if further large-scale studies will be needed
Anti-oxidative effects of 17 β-estradiol and genistein in human skin fibroblasts and keratinocytes
Teledermoscopy in the Diagnosis of Melanocytic and Non-Melanocytic Skin Lesions: NurugoTM Derma Smartphone Microscope as a Possible New Tool in Daily Clinical Practice
Background: Due to the COVID-19 pandemic, teledermoscopy has been increasingly
used in the remote diagnosis of skin cancers. In a study conducted in 2020, we demonstrated a
potential role of an inexpensive device (NurugoTM Derma) as a first triage to select the skin lesions
that require a face-to-face consultation with dermatologists. Herein, we report the results of a
novel study that aimed to better investigate the performance of NurugoTM. Objectives: (i) verify
whether the NurugoTM can be a communication tool between the general practitioner (GP) and
dermatologist in the first assessment of skin lesions, (ii) analyze the degree of diagnostic–therapeutic
agreement between dermatologists, (iii) estimate the number of potentially serious diagnostic errors.
Methods: One hundred and forty-four images of skin lesions were collected at the Dermatology
Outpatient Clinic in Novara using a conventional dermatoscope (instrument F), the NurugoTM
(instrument N), and the latter with the interposition of a laboratory slide (instrument V). The images
were evaluated in-blind by four dermatologists, and each was asked to make a diagnosis and to
specify a possible treatment. Results: Our data show that F gave higher agreement values for all
dermatologists, concerning the real clinical diagnosis. Nevertheless, a medium/moderate agreement
value was obtained also for N and V instruments and that can be considered encouraging and indicate
that all examined tools can potentially be used for the first screening of skin lesions. The total amount
of misclassified lesions was limited (especially with the V tool), with up to nine malignant lesions
wrongly classified as benign. Conclusions: NurugoTM, with adequate training, can be used to build
a specific support network between GP and dermatologist or between dermatologists. Furthermore,
its use could be extended to the diagnosis and follow-up of other skin diseases, especially for frail
patients in emergencies, such as the current pandemic context
- …